A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Varespladib | CAS 172733-42-5 - Request Quote

Picture of Varespladib
SZ CAT No:SZ-V048001
CAS No
172733-42-5
Mol.F.
C21H19N2O5 : Na
Mol.Wt.
379.4 : 23.0
Inv. Status
Synthesis on demand
Rel. CAS No172732-68-2 (free base)
Shipping Condition Room Temperature

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Varespladib is chemically Sodium 2-((3-(2-amino-2-oxoacetyl)-1-benzyl-2-ethyl-1H-indol-4-yl)oxy)acetate. Varespladib is supplied with detailed characterization data compliant with regulatory guideline. Varespladib can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Varespladib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 172733-42-5

Purchase 172733-42-5

Order 172733-42-5

Enquire 172733-42-5

price of 172733-42-5

172733-42-5 Supplier

172733-42-5 Manufacturer

172733-42-5 Exporter

buy high quality Varespladib

Purchase Varespladib

Varespladib suppliers

Varespladib manufacturers

Varespladib price

Order Varespladib

Enquire Varespladib

Varespladib cost

Varespladib Supplier

Varespladib Distributor

Varespladib for Method Validation

Varespladib Reference Standard

Varespladib for ANDA Filing

Varespladib for Forced Degradation Studies

Varespladib Identification Standards

Varespladib for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,